Global and China Sustained Release Injectables Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Sustained Release Injectables industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Novartis

    • Eli Lilly

    • Ascendis Pharma

    • Sanofi

    • Aurobindo

    • Critical Pharmaceuticals

    • Camurus

    • Biomarin

    • Roche

    • Avadel

    • Taiwan Liposome Company

    • Alkermes

    • Amylin

    • AstraZeneca

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Naltrexone

    • Exenatide

    • Estradiol

    • Other

    Application:

    • Diabetes

    • Leukemia

    • Acromegaly

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Sustained Release Injectables Industry Overview

      • 1.1.1 Sustained Release Injectables Market Scope and Market Segments

      • 1.1.2 Sustained Release Injectables Industry Characteristics

      • 1.1.3 Global and China Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Sustained Release Injectables Production Value and Growth Rate (2017-2028)

    • 1.2 Global Sustained Release Injectables Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Naltrexone

      • 1.2.2 Exenatide

      • 1.2.3 Estradiol

      • 1.2.4 Other

    • 1.3 Global Sustained Release Injectables Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Diabetes

      • 1.3.2 Leukemia

      • 1.3.3 Acromegaly

      • 1.3.4 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Sustained Release Injectables Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Sustained Release Injectables Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Sustained Release Injectables Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Sustained Release Injectables Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Sustained Release Injectables Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Sustained Release Injectables Industry Porter's Five Forces Model Analysis

      • 2.2.3 Sustained Release Injectables Industry PEST Analysis

    • 2.3 Sustained Release Injectables Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Sustained Release Injectables Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Sustained Release Injectables Industry

    Chapter 3 Global and China Sustained Release Injectables Market, by Manufacturer

    • 3.1 Global and China Sustained Release Injectables Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Sustained Release Injectables Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Sustained Release Injectables Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Sustained Release Injectables Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Sustained Release Injectables Market Top 3 Players

    Chapter 4 Global and China Sustained Release Injectables Market, by Type (2017-2028)

    • 4.1 Sustained Release Injectables Market Trend, by Type

    • 4.2 Global Sustained Release Injectables Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Sustained Release Injectables Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Sustained Release Injectables Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Sustained Release Injectables Price Trend, by Type (2017-2028)

    • 4.3 China Sustained Release Injectables Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Sustained Release Injectables Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Sustained Release Injectables Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Sustained Release Injectables Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Sustained Release Injectables Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Sustained Release Injectables Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Sustained Release Injectables Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Sustained Release Injectables Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Sustained Release Injectables Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Sustained Release Injectables Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Sustained Release Injectables Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Sustained Release Injectables Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Sustained Release Injectables Market Analysis

    • 7.1 North America Sustained Release Injectables Market, by Type

    • 7.2 North America Sustained Release Injectables Market, by Application

    • 7.3 North America Sustained Release Injectables Market Analysis and Forecast, by Country

      • 7.3.1 United States Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Sustained Release Injectables Market Analysis

    • 8.1 Europe Sustained Release Injectables Market, by Type

    • 8.2 Europe Sustained Release Injectables Market, by Application

    • 8.3 Europe Sustained Release Injectables Market Analysis and Forecast, by Country

      • 8.3.1 Germany Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Sustained Release Injectables Market Analysis

    • 9.1 APAC Sustained Release Injectables Market, by Type

    • 9.2 APAC Sustained Release Injectables Market, by Application

    • 9.3 APAC Sustained Release Injectables Market Analysis and Forecast, by Country

      • 9.3.1 China Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Sustained Release Injectables Market Analysis

    • 10.1 Latin America, Middle East and Africa Sustained Release Injectables Market, by Type

    • 10.2 Latin America, Middle East and Africa Sustained Release Injectables Market, by Application

    • 10.3 Latin America, Middle East and Africa Sustained Release Injectables Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Sustained Release Injectables Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Sustained Release Injectables Company Profiles

      • 11.1 Novartis

        • 11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Novartis Sustained Release Injectables Product Profiles, Application and Specification

        • 11.1.3 Novartis Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eli Lilly

        • 11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eli Lilly Sustained Release Injectables Product Profiles, Application and Specification

        • 11.2.3 Eli Lilly Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ascendis Pharma

        • 11.3.1 Ascendis Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ascendis Pharma Sustained Release Injectables Product Profiles, Application and Specification

        • 11.3.3 Ascendis Pharma Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sanofi

        • 11.4.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sanofi Sustained Release Injectables Product Profiles, Application and Specification

        • 11.4.3 Sanofi Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Aurobindo

        • 11.5.1 Aurobindo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Aurobindo Sustained Release Injectables Product Profiles, Application and Specification

        • 11.5.3 Aurobindo Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Critical Pharmaceuticals

        • 11.6.1 Critical Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Critical Pharmaceuticals Sustained Release Injectables Product Profiles, Application and Specification

        • 11.6.3 Critical Pharmaceuticals Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Camurus

        • 11.7.1 Camurus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Camurus Sustained Release Injectables Product Profiles, Application and Specification

        • 11.7.3 Camurus Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Biomarin

        • 11.8.1 Biomarin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Biomarin Sustained Release Injectables Product Profiles, Application and Specification

        • 11.8.3 Biomarin Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Roche

        • 11.9.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Roche Sustained Release Injectables Product Profiles, Application and Specification

        • 11.9.3 Roche Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Avadel

        • 11.10.1 Avadel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Avadel Sustained Release Injectables Product Profiles, Application and Specification

        • 11.10.3 Avadel Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Taiwan Liposome Company

        • 11.11.1 Taiwan Liposome Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Taiwan Liposome Company Sustained Release Injectables Product Profiles, Application and Specification

        • 11.11.3 Taiwan Liposome Company Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Alkermes

        • 11.12.1 Alkermes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Alkermes Sustained Release Injectables Product Profiles, Application and Specification

        • 11.12.3 Alkermes Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Amylin

        • 11.13.1 Amylin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Amylin Sustained Release Injectables Product Profiles, Application and Specification

        • 11.13.3 Amylin Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 AstraZeneca

        • 11.14.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 AstraZeneca Sustained Release Injectables Product Profiles, Application and Specification

        • 11.14.3 AstraZeneca Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Sustained Release Injectables Industry Investment Prospect and Risk Assessment

    • 12.1 Sustained Release Injectables Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Sustained Release Injectables Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure China Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Global Sustained Release Injectables Production Value and Growth Rate (2017-2028)

    • Figure China Sustained Release Injectables Production Value and Growth Rate (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Naltrexone (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Exenatide (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Estradiol (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Diabetes (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Leukemia (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Acromegaly (2017-2028)

    • Figure Global Sustained Release Injectables Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Sustained Release Injectables Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Sustained Release Injectables Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Sustained Release Injectables Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Sustained Release Injectables Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Sustained Release Injectables Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Sustained Release Injectables Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Sustained Release Injectables Market Share, by Manufacturer in 2021

    • Figure Global and China Sustained Release Injectables Market Share, by Manufacturer in 2022

    • Table Global Sustained Release Injectables Sales Volume, by Type (2017-2028)

    • Table Global Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Figure Global Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Table Global Sustained Release Injectables Sales Value, by Type (2017-2028)

    • Table Global Sustained Release Injectables Sales Value Share, by Type (2017-2028)

    • Figure Global Sustained Release Injectables Price Trend, by Type (2017-2028)

    • Table China Sustained Release Injectables Sales Volume, by Type (2017-2028)

    • Table China Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Figure China Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Table China Sustained Release Injectables Sales Value, by Type (2017-2028)

    • Table China Sustained Release Injectables Sales Value Share, by Type (2017-2028)

    • Figure China Sustained Release Injectables Price Trend, by Type (2017-2028)

    • Table Global Sustained Release Injectables Sales Volume, by Application (2017-2028)

    • Table Global Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure Global Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Table Global Sustained Release Injectables Sales Value, by Application (2017-2028)

    • Table Global Sustained Release Injectables Sales Value Share, by Application (2017-2028)

    • Figure Global Sustained Release Injectables Sales Value Share, by Application (2017-2028)

    • Table China Sustained Release Injectables Sales Volume, by Application (2017-2028)

    • Table China Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure China Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Table China Sustained Release Injectables Sales Value, by Application (2017-2028)

    • Table China Sustained Release Injectables Sales Value Share, by Application (2017-2028)

    • Figure China Sustained Release Injectables Sales Value Share, by Application (2017-2028)

    • Figure China Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • Figure North America Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Sustained Release Injectables Production, Import, Consumption and Export (2017-2022)

    • Table North America Sustained Release Injectables Sales Volume, by Type (2017-2028)

    • Table North America Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Figure North America Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Table North America Sustained Release Injectables Sales Volume, by Application (2017-2028)

    • Table North America Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure North America Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure United States Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure United States Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Canada Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Table Europe Sustained Release Injectables Sales Volume, by Type (2017-2028)

    • Table Europe Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Figure Europe Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Table Europe Sustained Release Injectables Sales Volume, by Application (2017-2028)

    • Table Europe Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure Europe Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure Germany Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure UK Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure UK Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure France Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure France Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Italy Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Spain Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Poland Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Russia Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Table APAC Sustained Release Injectables Sales Volume, by Type (2017-2028)

    • Table APAC Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Figure APAC Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Table APAC Sustained Release Injectables Sales Volume, by Application (2017-2028)

    • Table APAC Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure APAC Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure China Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure China Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Japan Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure India Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure India Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Sustained Release Injectables Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Sustained Release Injectables Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Sustained Release Injectables Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Sustained Release Injectables Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Sustained Release Injectables Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Sustained Release Injectables Sales Value and Growth Rate (2017-2028)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ascendis Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ascendis Pharma Product Profiles, Application and Specification

    • Table Ascendis Pharma Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Aurobindo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Aurobindo Product Profiles, Application and Specification

    • Table Aurobindo Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Critical Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Critical Pharmaceuticals Product Profiles, Application and Specification

    • Table Critical Pharmaceuticals Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Camurus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Camurus Product Profiles, Application and Specification

    • Table Camurus Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biomarin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biomarin Product Profiles, Application and Specification

    • Table Biomarin Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Avadel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Avadel Product Profiles, Application and Specification

    • Table Avadel Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Taiwan Liposome Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Taiwan Liposome Company Product Profiles, Application and Specification

    • Table Taiwan Liposome Company Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alkermes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alkermes Product Profiles, Application and Specification

    • Table Alkermes Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amylin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amylin Product Profiles, Application and Specification

    • Table Amylin Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Sustained Release Injectables Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.